IP Library Granted Patent US 8,865,149
Granted Patent B2
US 8,865,149 · App. 11/714,322 · Granted Oct 21, 2014

Polymeric reagents comprising a ketone or a related functional group

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,865,149
App. No.
11/714,322
Granted
Oct 21, 2014
Kind
B2
Abstract

Polymeric reagents comprising a polymer attached, either directly or through one or more atoms, to a ketone or a related functional group such as ketone hydrate, thione, monothiohydrate, dithiohydrate, hemiketal, monothiohemiketal, dithiohemiketal, ketal, or dithioketal are provided. The polymeric reagents are useful for, among other things, forming polymer-active agent conjugates. Related methods, compositions, preparations, and so forth are also provided.

Claims (9)

1. A conjugate, wherein the conjugate has the structure

wherein mPEG is a methoxy capped poly(ethylene glycol) having a nominal average molecular weight of from about 2,500 Daltons to about 100,000 Daltons and

is an amine-containing active agent.

2. The conjugate of claim 1 , wherein the mPEG has a nominal average molecular weight of from about 4,900 Daltons to about 40,000 Daltons.

3. The conjugate of claim 2 , wherein the mPEG has a nominal average molecular weight of from about 9,900 Daltons to about 25,000 Daltons.

4. The conjugate of claim 1 , wherein the mPEG has a nominal average molecular weight of about 5,000 Daltons.

5. The conjugate of claim 1 , wherein the active agent is selected from erythropoietin, granulocyte macrophage colony stimulating factor (GMCSF), granulocyte colony stimulating factor (GCSF), interferon alpha, interferon beta, human growth hormone, amphotericin B, and follicle stimulating hormone.

6. The conjugate of claim 1 , wherein the active agent is a polypeptide.

7. A pharmaceutical preparation comprising the conjugate of claim 1 and a pharmaceutically acceptable excipient.

Assignments (5)
RELEASE OF SECURITY INTEREST Recorded Apr 17, 2020
From: TC LENDING, LLC, AS COLLATERAL AGENT
To: NEKTAR THERAPEUTICS
Reel/Frame 053180/0009 →
RELEASE OF SECURITY INTEREST RECORDED AT REEL 28571, FRAME 0141 Recorded Oct 14, 2015
From: WELLS FARGO BANK, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
To: NEKTAR THERAPEUTICS
Reel/Frame 036866/0700 →
GRANT OF SECURITY INTEREST IN UNITED STATES PATENTS Recorded Oct 6, 2015
From: NEKTAR THERAPEUTICS
To: TC LENDING, LLC, AS COLLATERAL AGENT
Reel/Frame 036796/0562 →
GRANT OF SECURITY INTEREST Recorded Jul 17, 2012
From: NEKTAR THERAPEUTICS
To: WELLS FARGO BANK, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 028571/0141 →
MERGER Recorded Aug 31, 2009
From: NEKTAR THERAPEUTICS AL, CORPORATION
To: NEKTAR THERAPEUTICS
Reel/Frame 023196/0394 →